Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial

DSpace Repository

Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial

Author: Dimopoulos, Meletios; Weisel, Katja; van de Donk, Niels W. C. J.; Ramasamy, Karthik; Gamberi, Barbara; Streetly, Matthew; Offidani, Massimo; Bridoux, Frank; de la Rubia, Javier; Mateos, Maria-Victoria; Ardizzoia, Antonio; Kueenburg, Elisabeth; Collins, Shona; Di Micco, Antonia; Rosettani, Barbara; Li, Yan; Bacon, Pamela; Sonneveld, Pieter
Tübinger Autor(en):
Weisel, Katja
Published in: Journal of Clinical Oncology (2018), Bd. 36, H. 20, S. 2035-2043
Verlagsangabe: Amer Soc Clinical Oncology
Language: English
Full text: http://dx.doi.org/10.1200/JCO.2017.76.1742
ISSN: 1527-7755
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
ConferenceObject
Show full item record

This item appears in the following Collection(s)